The CD47-SIRPα pathway in cancer immune evasion and potential therapeutic implications

被引:508
作者
Chao, Mark P. [1 ,2 ]
Weissman, Irving L. [1 ,2 ]
Majeti, Ravindra [1 ,2 ,3 ]
机构
[1] Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA
[2] Inst Canc Res, Stanford, CA 94305 USA
[3] Stanford Univ, Sch Med, Dept Internal Med, Div Hematol, Stanford, CA 94305 USA
关键词
INTEGRIN-ASSOCIATED PROTEIN; COLONY-STIMULATING FACTOR; REGULATORY PROTEIN; FC-GAMMA; CALRETICULIN EXPOSURE; MONOCLONAL-ANTIBODY; CD20; EXPRESSION; DOWN-REGULATION; DENDRITIC CELL; T-CELL;
D O I
10.1016/j.coi.2012.01.010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
Multiple lines of investigation have demonstrated that the immune system plays an important role in preventing tumor initiation and controlling tumor growth. Accordingly, many cancers have evolved diverse mechanisms to evade such monitoring. While multiple immune cell types mediate tumor surveillance, recent evidence demonstrates that macrophages, and other phagocytic cells, play a key role in regulating tumor growth through phagocytic clearance. In this review we highlight the role of tumor immune evasion through the inhibition of phagocytosis, specifically through the CD47- signal-regulatory protein-alpha pathway, and discuss how targeting this pathway might lead to more effective cancer immunotherapies.
引用
收藏
页码:225 / 232
页数:8
相关论文
共 54 条
[1]
Adams S, 1998, J IMMUNOL, V161, P1853
[2]
The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance [J].
Allavena, Paola ;
Sica, Antonio ;
Garlanda, Cecilia ;
Mantovani, Alberto .
IMMUNOLOGICAL REVIEWS, 2008, 222 :155-161
[3]
CD47 (integrin-associated protein) engagement of dendritic cell and macrophage counterreceptors is required to prevent the clearance of donor lymphohematopoietic cells [J].
Blazar, BR ;
Lindberg, FP ;
Ingulli, E ;
Panoskaltsis-Mortari, A ;
Oldenborg, PA ;
Iizuka, K ;
Yokoyama, WM ;
Taylor, PA .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (04) :541-549
[4]
Integrin-associated protein (CD47) and its ligands [J].
Brown, EJ ;
Frazier, WA .
TRENDS IN CELL BIOLOGY, 2001, 11 (03) :130-135
[5]
Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells [J].
Chan, Keith Syson ;
Espinosa, Inigo ;
Chao, Mark ;
Wong, David ;
Ailles, Laurie ;
Diehn, Max ;
Gill, Harcharan ;
Presti, Joseph, Jr. ;
Chang, Howard Y. ;
van de Rijn, Matt ;
Shortliffe, Linda ;
Weissman, Irving L. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (33) :14016-14021
[6]
Extranodal dissemination of non-Hodgkin lymphoma requires CD47 and is inhibited by anti-CD47 antibody therapy [J].
Chao, Mark P. ;
Tang, Chad ;
Pachynski, Russell K. ;
Chin, Robert ;
Majeti, Ravindra ;
Weissman, Irving L. .
BLOOD, 2011, 118 (18) :4890-4901
[7]
Therapeutic Antibody Targeting of CD47 Eliminates Human Acute Lymphoblastic Leukemia [J].
Chao, Mark P. ;
Alizadeh, Ash A. ;
Tang, Chad ;
Jan, Max ;
Weissman-Tsukamoto, Rachel ;
Zhao, Feifei ;
Park, Christopher Y. ;
Weissman, Irving L. ;
Majeti, Ravindra .
CANCER RESEARCH, 2011, 71 (04) :1374-1384
[8]
Calreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers and Is Counterbalanced by CD47 [J].
Chao, Mark P. ;
Jaiswal, Siddhartha ;
Weissman-Tsukamoto, Rachel ;
Alizadeh, Ash A. ;
Gentles, Andrew J. ;
Volkmer, Jens ;
Weiskopf, Kipp ;
Willingham, Stephen B. ;
Raveh, Tal ;
Park, Christopher Y. ;
Majeti, Ravindra ;
Weissman, Irving L. .
SCIENCE TRANSLATIONAL MEDICINE, 2010, 2 (63)
[9]
Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma [J].
Chao, Mark P. ;
Alizadeh, Ash A. ;
Tang, Chad ;
Myklebust, June H. ;
Varghese, Bindu ;
Gill, Saar ;
Jan, Max ;
Cha, Adriel C. ;
Chan, Charles K. ;
Tan, Brent T. ;
Park, Christopher Y. ;
Zhao, Feifei ;
Kohrt, Holbrook E. ;
Malumbres, Raquel ;
Briones, Javier ;
Gascoyne, Randy D. ;
Lossos, Izidore S. ;
Levy, Ronald ;
Weissman, Irving L. ;
Majeti, Ravindra .
CELL, 2010, 142 (05) :699-713
[10]
Chao MP, 2011, NAT REV CANC